Clinical Trials Logo

Renal Limited Vasculitis clinical trials

View clinical trials related to Renal Limited Vasculitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT00753103 Completed - Clinical trials for Microscopic Polyangiitis

Anti-Cytokine Therapy for Vasculitis

ACTIVE
Start date: January 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Infliximab (monoclonal anti-tumour necrosis factor alpha antibodies) are safe and effective in the treatment of anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis.

NCT ID: NCT00307645 Terminated - Clinical trials for Renal Limited Vasculitis

IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

Start date: May 2003
Phase: Phase 3
Study type: Interventional

The aim of IMPROVE is to define the optimal maintenance therapy for ANCA-associated vasculitides (AASV) by comparing the AZA (standard regimen) with MMF in terms of efficacy, i.e. in preventing relapses. HYPOTHESIS : MMF might be more effective than azathioprine as maintenance drug in AASV patients, reducing by 50% relapse rate, with a same frequency of adverse effects